Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 6:31 PM ET

Date/Time Source News Release
05/05/2025 08:00 AM EDT GlobeNewswire iBio's First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical Model
05/02/2025 08:00 AM EDT GlobeNewswire iBio Reports Fiscal Third Quarter 2025 Financial Results
04/29/2025 01:43 PM EDT GlobeNewswire iBio Raises $6.2 Million Through Warrant Inducement Transaction
04/22/2025 08:00 AM EDT GlobeNewswire iBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBio
04/07/2025 07:00 AM EDT GlobeNewswire iBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity Pipeline
02/19/2025 04:05 PM EST GlobeNewswire iBio to Begin Trading on the Nasdaq Stock Exchange
02/10/2025 04:05 PM EST GlobeNewswire iBio Reports Fiscal Second Quarter 2025 Financial Results
01/13/2025 07:00 AM EST GlobeNewswire iBio Announces New Investments from Board Members and Officers
01/07/2025 07:00 AM EST GlobeNewswire iBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBio
01/02/2025 07:00 AM EST GlobeNewswire iBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBio
Page

Additional News

As of June 9, 2025 • 6:31 PM ET

Date/Time Source News Release
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:30 AM EDT US Earnings Reports Expected earnings - iBio Inc.
05/02/2025 08:06 AM EDT SeekingAlpha iBio GAAP EPS of -$0.49 misses by $0.24
04/29/2025 02:30 PM EDT PRISM News PRISM Mid-Day Movers: Weight Loss Index Gains on GLP-1 Offerings
04/28/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Strategic Deals in Energy and Pharma Contrast Broader Market Cooldown
04/22/2025 03:00 PM EDT PRISM News PRISM Mid-Day Movers: AI Auto Assistants and Obesity Innovation Spark Index Volatility
04/22/2025 12:31 PM EDT PRISM News iBio Adds New Obesity Drug Candidate to Pipeline, Targets Fat Loss Without Muscle Loss
02/10/2025 05:19 PM EST SeekingAlpha iBio GAAP EPS of -$0.48
01/31/2025 05:25 PM EST SeekingAlpha iBio files for secondary offering
01/02/2025 07:04 AM EST SeekingAlpha iBio expands cardiometabolic and obesity program
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.